Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne Vulgaris
Clinical trial NCT05550337 · COMPLETED
Trial details
- NCT number
- NCT05550337
- Sponsor
- Teva Pharmaceuticals USA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-19
- Primary completion
- 2023-05-09
- Enrollment
- 807
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.